MedPage Today 
(8/17, Smith) reports, "The antibiotic most commonly prescribed for
some bloodstream infections in dialysis patients may not be the best
choice," according to a
study
published online in the Journal of the American Society of Nephrology.
Investigators found that "nearly 60% of a large cohort with bacteremia
caused by methicillin-susceptible Staphylococcus aureus (MSSA) was
treated with vancomycin (Vancocin)." Just "one in six patients was
treated with cefazolin
(Ancef), although the drug was associated with a markedly lower risk of
hospital admission or death."
No comments:
Post a Comment